Influence of schedule of interleukin 2 administration on therapy with interleukin 2 and lymphokine activated killer cells.
about
Novel immunotherapy in metastatic renal cell carcinoma.A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part II: Immunological aspects.Immunotherapy with low-dose recombinant interleukin 2 after high-dose chemotherapy and autologous stem cell transplantation in neuroblastomaActivation of the immune system of cancer patients by continuous i.v. recombinant IL-2 (rIL-2) therapy is dependent on dose and schedule of rIL-2.Immunomodulation during prolonged treatment with combined interleukin-2 and interferon-alpha in patients with advanced malignancyImmunomodulatory effects of intravenous BIS-1 F(ab')2 administration in renal cell cancer patients.
P2860
Influence of schedule of interleukin 2 administration on therapy with interleukin 2 and lymphokine activated killer cells.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Influence of schedule of inter ...... hokine activated killer cells.
@en
type
label
Influence of schedule of inter ...... hokine activated killer cells.
@en
prefLabel
Influence of schedule of inter ...... hokine activated killer cells.
@en
P2093
P1433
P1476
Influence of schedule of inter ...... hokine activated killer cells.
@en
P2093
Lindgren CG
Thompson JA
P304
P407
P577
1989-01-01T00:00:00Z